Skip to main content
. 2022 Jun 2;25(7):104513. doi: 10.1016/j.isci.2022.104513

Figure 4.

Figure 4

The average flux produced from community models

(A) The average flux for SCFAs from personalized community models for patients with Swedish T2D (pink) compared to the average flux for SCFAs from personalized community models for matched controls (blue).

(B) The average flux for AAs lysine, tyrosine, and histidine from personalized community models for patients with Swedish T2D (pink) compared to the average flux for AAs from personalized community models for matched controls (blue).

(C) The average flux for BCAAs from personalized community models for patients with Swedish T2D (pink) compared to the average flux for BCAAs from personalized community models for matched controls (blue).

(D) The average flux for SCFAs from personalized community models for patients with Swedish ACVD (pink) compared to the average flux for SCFAs from personalized community models for matched controls (blue).

(E) The average flux for AAs lysine, tyrosine, and histidine from personalized community models for patients with Swedish ACVD (pink) compared to the average flux for AAs from personalized community models for matched controls (blue).

(F) The average flux for BCAAs from personalized community models for patients with Swedish ACVD (pink) compared to the average flux for BCAAs from personalized community models for matched controls (blue).